申请人:Synthelabo
公开号:US05589476A1
公开(公告)日:1996-12-31
A compound of formula (I): ##STR1## in which R.sub.1 represents a hydrogen atom or a straight or branched (C.sub.1 -C.sub.4)alkyl group; and A represents a 5,6-dihydro-4H-imidazo[4,5,1-ij]quinol-2-yl group, a 4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2-yl group, a 4-methyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2-yl group, a 4-phenyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2-yl group, a 4-phenylmethyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2-yl group, a 5-methyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2-yl group, a 5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-2-yl group, a 6-oxo-5,6-dihydro-4H-imidazo[4,5,1-ij]quinol-2-yl group, or a 5-methyl-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2-yl group which may be unsubstituted or substituted in the 6-position by a phenylmethyl group; or an addition salt thereof with a pharmaceutically acceptable acid.
式(I)的化合物:##STR1##其中R.sub.1代表氢原子或直链或支链(C.sub.1-C.sub.4)烷基基团;A代表5,6-二氢-4H-咪唑并[4,5,1-ij]喹啉-2-基基团,4,5-二氢咪唑并[1,5,4-de][1,4]苯并噁唑-2-基基团,4-甲基-4,5-二氢咪唑并[1,5,4-de][1,4]苯并噁唑-2-基基团,4-苯基-4,5-二氢咪唑并[1,5,4-de][1,4]苯并噁唑-2-基基团,4-苯甲基-4,5-二氢咪唑并[1,5,4-de][1,4]苯并噁唑-2-基基团,5-甲基-4,5-二氢咪唑并[1,5,4-de][1,4]苯并噁唑-2-基基团,5,6-二氢-4H-咪唑并[1,5,4-de]喹啉-2-基基团,6-氧代-5,6-二氢-4H-咪唑并[4,5,1-ij]喹啉-2-基基团,或5-甲基-4,5,6,7-四氢咪唑并[4,5,1-jk][1,4]苯并二氮杂环-2-基基团,该基团可以在6位被苯甲基基团取代或未取代;或其与药学上可接受的酸形成的盐。